Role of Rpn11 Metalloprotease in Deubiquitination and Degradation by the 26S Proteasome

See allHide authors and affiliations

Science  18 Oct 2002:
Vol. 298, Issue 5593, pp. 611-615
DOI: 10.1126/science.1075898


The 26S proteasome mediates degradation of ubiquitin-conjugated proteins. Although ubiquitin is recycled from proteasome substrates, the molecular basis of deubiquitination at the proteasome and its relation to substrate degradation remain unknown. The Rpn11 subunit of the proteasome lid subcomplex contains a highly conserved Jab1/MPN domain–associated metalloisopeptidase (JAMM) motif—EXnHXHX10D. Mutation of the predicted active-site histidines to alanine (rpn11AXA) was lethal and stabilized ubiquitin pathway substrates in yeast. Rpn11AXA mutant proteasomes assembled normally but failed to either deubiquitinate or degrade ubiquitinated Sic1 in vitro. Our findings reveal an unexpected coupling between substrate deubiquitination and degradation and suggest a unifying rationale for the presence of the lid in eukaryotic proteasomes.

Proteolysis by the 26Sproteasome proceeds by binding of the ubiquitinated substrate protein to the 19S regulatory particle, followed by its unfolding and translocation into the lumen of the 20S core, where it is degraded by the action of the 20S peptidases (1–3). At some point in this process, the ubiquitin targeting signal is detached from the substrate. It is appealing to envision that this deubiquitination is obligatorily coupled to degradation. Such coupling would render the targeting event irreversible, prevent unproductive turnover of ubiquitin, and presumably alleviate steric blockade of the 20S core entry portal by the bulky ubiquitin chain, which is linked by isopeptide bonds. When and where substrate deubiquitination takes place, the identity of the deubiquitinating enzyme (DUB), and whether deubiquitination of a substrate is essential for its degradation by the proteasome are unclear (4, 5).

Budding yeast ubiquitinated S-Cdk inhibitor Sic1 (Ub-Sic1) is rapidly degraded by purified 26S proteasomes (3,6) in a reaction that recapitulates physiological requirements for Sic1 proteolysis (7, 8). To investigate whether degradation of Sic1 is normally accompanied by its deubiquitination, we evaluated the fate of Ub-Sic1 after inhibition of 26S proteolytic activity. Epoxomicin inhibits the proteasome by covalently binding the catalytically active β subunits of the 20S core (9). Purified 26S proteasomes were preincubated with or without epoxomicin, Ub-Sic1 was then added, and degradation was monitored by the loss of Sic1 antigen. In the absence of epoxomicin, Ub-Sic1 was completely degraded (Fig. 1A; fig. S1). Surprisingly, in the presence of epoxomicin, a large fraction of Ub-Sic1 molecules were completely deubiquitinated, as judged by comigration with unmodified Sic1 and failure to cross-react with antibodies to ubiquitin (Fig. 1B).

Figure 1

Characterization of Ub-Sic1 deubiquitination by purified 26S proteasomes. (A) Ub-Sic1 is deubiquitinated by epoxomicin-treated 26Sproteasomes in a ubiquitin aldehyde–insensitive manner. Purified proteasomes (100 nM) were incubated with either 1% dimethyl sulfoxide (DMSO) (lanes 1 and 2, mock), or 100 μΜ epoxomicin in the absence (lane 3) or presence (lane 4) of 2.5 μM ubiquitin aldehyde (Ub-Al) for 30 min at 30°C. The degradation reaction was initiated by the addition of Ub-Sic1 (300 nM) and 1× ATP regenerating system (1× ARS) (3), incubated at 30°C for 5 min, and terminated by the addition of SDS sample buffer. Aliquots were resolved by SDS-PAGE (8% polyacrylamide gel), transferred to nitrocellulose, and immunoblotted with polyclonal antibody to Sic1 to monitor degradation. (B) Sic1 generated by epoxomicin-treated proteasomes is completely deubiquitinated. An aliquot of the epoxomicin-treated sample from lane 3 in (A) as well as a Ub-Sic1 preparation containing both Ub-Sic1 and unmodified Sic1 were resolved by SDS-PAGE and immunoblotted with antiserum to Sic1 (α-Sic1) (left) or to ubiquitin (α-Ub) (right). The anti-ubiquitin immunoreactivity is primarily derived from autoubiquitinated Cdc34 (30), which is not degraded (31). (C) Deubiquitination of Ub-Sic1 is ATP dependent. Mock- or epoxomicin-treated 26S proteasomes were depleted of ATP by 5 min of incubation with apyrase (15 units/ml) or hexokinase (5 units/ml) plus 30 mM glucose (Glu + HK) before incubation with Ub-Sic1. Lane 6 is the same as lane 2, except the DUB inhibitor ubiquitin vinyl sulfone (Ub-VS) (32) was included at 2.5 μM. (D) Subparticles of the 26S proteasome do not efficiently deubiquitinate Ub-Sic1. The 19S regulatory particle was isolated as described in (6). The lid subparticle of 19S was purified from a strain containing RPN8TEV2MYC9 as described (23). ACoomassie blue–stained preparation is shown in Fig. 4C. The three preparations—26S, 19S, and lid—were incubated in the absence (lanes 1, 2, 4, and 6) or presence (lanes 3, 5, and 7) of epoxomicin and assayed for degradation/ deubiquitination of Ub-Sic1 as described in (A). (E) Inhibition of deubiquitination by the metal chelator 1,10-phenanthroline. 26S proteasomes were preincubated at 30°C with 1% DMSO and 1% MeoH (lanes 1 and 2) or 100 μM epoxomicin and 1% MeOH (lane 3) containing in addition 1 mM 1,10-phenanthroline (lane 4), 1 mM 1,7-phenanthroline (lane 5), or 1 mM 1,10-phenanthroline premixed with 2 mM CoCl2 (lane 6) or 2 mM CoCl2 (lane 7). The degradation reaction was initiated by the addition of Ub-MbpSic1.

Conversion of Ub-Sic1 to Sic1 differed from conventional thiol protease–mediated deubiquitination in four respects: (i) it was insensitive to the classic DUB inhibitors ubiquitin aldehyde (Ub-Al) and ubiquitin vinyl sulfone (Ub-VS) (Fig. 1, A and C); (ii) it required adenosine triphosphate (ATP) (Fig. 1C); (iii) it required intact 26S proteasome and was not sustained by 19Sregulatory particle or the lid (Fig. 1D); and (iv) it was completely blocked by o-phenanthroline (1,10-phenanthroline), but notm-phenanthroline (1,7-phenanthroline) oro-phenanthroline presaturated with cobalt ions (Fig. 1E). These four properties suggest that a metallopeptidase was responsible for this activity. These properties are reminiscent of an unidentified deubiquitinating activity that copurifies with 26Sproteasomes from rabbit reticulocyte lysates (10).

We had characterized our proteasome preparation by mass spectrometry, which revealed only a single known DUB, Ubp6 (3) (table S1). However, Ubp6 was neither necessary nor sufficient for processing Ub-Sic1 (fig. S2). Thus, we reasoned that the DUB activity we observed might reside in a proteasome subunit that harbors a novel ubiquitin isopeptidase activity.

The lid subcomplex of the 19S regulatory particle is necessary for ubiquitin-dependent degradation (11). The lid subunits share sequence conservation with subunits of the COP9 signalosome (CSN). CSN preparations contain an isopeptidase activity that promotes cleavage of the ubiquitin-like molecule Nedd8 from Nedd8–Cul1 conjugates (12). The Csn5/Jab1 subunit of CSN (13, 14) and the Rpn11 subunit of the lid (Fig. 2A) contain a distinct arrangement of two histidines and an aspartate preceded by a conserved but variably spaced glutamate (EXnHXHX10D) (15). We refer to this motif as JAMM for Jab1/Pad1/MPN domain metalloenzyme. We propose that the histidines and aspartate bind a zinc ion, which, together with the upstream glutamate, comprise an active site (14).

Figure 2

Rpn11, an intrinsic subunit of the lid subcomplex of the 19S regulatory particle, contains a conserved, predicted metalloprotease motif (JAMM) that is critical for viability. (A) Sequence alignment ofRPN11 orthologs with human CSN5/JAB1 reveals the JAMM motif. The multiple alignment was constructed by using the T-Coffee program (33). Each protein is denoted by its name followed by an abbreviated species name. The predicted metal-chelating and catalytic residues are shown as a consensus below the alignment. For a detailed description of the extended JAMM domain consensus based on all RPN11 orthologs, see fig. S3. (B) An intact JAMM motif is critical for yeast cell proliferation. Anrpn11Δ::KAN strain kept alive by an [RPN11 URA3] plasmid (RJD 1922) was transformed withLEU2-marked RPN11 (RJD 1934) or rpn11AXAplasmids (RJD 1935) (23). Transformants (two representative clones each) were streaked onto 5-fluoroorotic acid (FOA) plates and allowed to grow for 5 days at 25°C. Because 5-FOA is toxic to URA3 cells, growth is observed only when theURA3-marked plasmid is rendered dispensable by theLEU2 plasmid. (C) The rpn11AXA mutant cannot complement the mpr1-1temperature-sensitive allele of RPN11. mpr1-1(RJD 1786) was transformed with either empty pRS316 [URA3] vector or vector containing wild-typeRPN11 (RJD 1815) or rpn11AXA (RJD 1816). Individual transformants were streaked on synthetic minimal (SD)–Ura plates and incubated at 25°C or 37°C for 5 days.

To evaluate the role of the JAMM motif of Rpn11 in the metal ion–dependent deubiquitination shown in Fig. 1E, we mutated the two conserved histidines to alanines (henceforth referred to as therpn11AXA mutant; table S3). Because Rpn11 is an essential protein (16), we evaluated the effect of the mutation by plasmid shuffling. A haploid rpn11Δ leu2 ura3 strain sustained by a [RPN11 URA3] plasmid was transformed with LEU2 plasmids containing eitherRPN11 or rpn11AXA. Transformants that harbored [rpn11AXA LEU2] were unable to survive without the [RPN11 URA3] plasmid (Fig. 2B), indicating that an intact Rpn11 JAMM motif was critical. To facilitate further phenotypic characterization of the AXA mutant, we usedmpr1-1, which contains a frameshift in RPN11 that leads to temperature-sensitive growth and expression of a prematurely terminated Rpn11mpr1-1 protein (285 versus 306 amino acids for wild type) (16). Plasmid-borne RPN11but not rpn11AXA complemented the temperature-sensitive growth of mpr1-1 (Fig. 2C).

Rpn11 and other subunits of the 19S regulatory particle may mediate transcriptional regulation and DNA repair independent of their roles in proteolysis (17, 18). To test whether the inability of rpn11AXA to sustain viability might be due to defective protein degradation, we evaluated the stability of an artificial ubiquitin fusion degradation (UFD) pathway substrate (19) and the anaphase-promoting complex/cyclosome substrate Clb2 (20) in wild-type, mpr1-1,mpr1-1/RPN11, andmpr1-1/rpn11AXA cells. For the latter experiment, cells were arrested in the G1 phase of the cell cycle with α factor, at which time Clb2 proteolysis proceeds rapidly.RPN11, but not rpn11AXA, complemented the degradation defects observed for both proteins inmpr1-1 cells (Fig. 3). Thus, the JAMM motif was essential for substrate proteolysis by the 26Sproteasome in vivo. Paradoxically, substrates that accumulated inrpn11AXA cells were not ubiquitinated. However, when proteolysis is blocked by mutations in proteasome subunits (21) or the DUB Doa4 (22), substrates accumulate primarily in an unmodified form, presumably because of robust activity of “scavenging” DUBs.

Figure 3

An intact JAMM motif is required for degradation of ubiquitin–proteasome pathway substrates in vivo. (A) Stabilization of a UFD pathway substrate in mutant cells. RPN11 (RJD1901), mpr1-1 (RJD 1902), mpr1-1 RPN11 (RJD 1903), andmpr1-1 rpn11AXA (RJD 1904) strains (23) containing a reporter plasmid expressing the unstable Ub-V76-Val-eK-B-Gal fusion protein were analyzed by pulse-chase35S radiolabeling as described in (6). Arrow indicates the 35S-labeled substrate protein, and filled circle shows the position of the 90-kD stable breakdown product of the reporter protein. (B) Stabilization of mitotic cyclin Clb2 in mpr1-1 rpn11AXA cells. Mutantmpr1-1 RPN11 (RJD 2002) andmpr1-1/rpn11AXA (RJD 2004) strains harboring a chromosomally encoded, influenza hemagglutinin antigen (HA)–tagged GAL-CLB2 expression cassette (23) were grown in raffinose medium (R) at 25°C, and Clb2 expression was induced by the addition of 2% galactose (G). To confirm specific expression of Clb2-HA3, we prepared cell lysates by lysing with glass beads and boiling. Aliquots were resolved by SDS-PAGE, transferred to nitrocellulose, and analyzed by immunoblotting with 12CA5 antibody to HA ascites (left). For evaluation of Clb2-HA3 stability (right), cultures were grown in raffinose (R) medium at 25°C and arrested in G1 by the addition of α-factor (5 μg/ml) for 2 hours. Clb2 expression was induced with galactose for 1.5 hours, and cultures were shifted to 36°C to inactivatempr1-1. After 1.5 hours, cells were transferred to α-factor–containing dextrose (D) medium at 37°C to extinguish expression of Clb2. Because there is continuous proteolysis of Clb2 in α-factor–arrested cells, and time 0 was collected after washing and resuspension in yeast extract, peptone, and dextrose, the level is much less than that seen in exponential by growing cells (left). Asterisk denotes a nonspecific immunoreactive band to HA.

To determine the biochemical basis of the rpn11AXAdegradation defect, we sought to evaluate the activity of Rpn11AXA proteasomes in vitro. We affinity-purified proteasomes from an mpr1-1 strain harboring a chromosomal copy of either RPN11 or rpn11AXA(23). Immunoblotting with antiserum to Pad1/Rpn11 (24) revealed that extracts from RPN11and mpr1-1 contained full-length and truncated Rpn11, respectively, whereas extracts from thempr1-1/RPN11 and mpr1-1/rpn11AXAstrains contained both polypeptides (Fig. 4A). Fortuitously, no truncated Rpn11mpr1-1 was present in 26S proteasomes prepared from mpr1-1 strains. This allowed us to prepare point-mutant 26S proteasomes that contained Rpn11AXA, with no contamination by Rpn11mpr1-1.

Figure 4

The JAMM motif is not required for assembly or peptidase activity of 26S proteasomes, but it is required for deubiquitination and degradation of Ub-Sic1 in vitro. A set of four congenic strains—RPN11 (RJD 1869),mpr1-1 (RJD 1900), mpr1-1 RPN11 (RJD 1867), and mpr1-1 rpn11AXA (RJD 1868)—that each expresses a chromosomally encoded FlagHis6-tagged Pre1 (23) were grown at 25°C, and extracts were prepared by lysing with glass beads and boiling in SDS sample buffer. 26S proteasomes were purified by Flag affinity chromatography from these strains as well, as described in (6). (A) Analysis of extracts and 26Sproteasomes by immunoblotting for Rpn11. Aliquots of crude lysate (lanes 1 to 4) and purified proteasomes (lanes 5 to 7) were resolved by SDS-PAGE, transferred to nitrocellulose, and immunoblotted with antiserum to Pad1, the Schizosaccharomyces pombe Rpn11 ortholog (24). (B and C)mpr1-1 but not rpn11AXA mutation alters polypeptide composition of 26S proteasome. Proteasomes isolated from the indicated strains were fractionated by SDS-PAGE and stained with Coomassie blue. The lid subparticle shown in (C) was purified as described in (23). (D)rpn11AXA mutation does not perturb assembly of the 19S regulatory particle. Purified 26S proteasomes were evaluated by immunoblotting with antibodies specific for the indicated proteasome subunits. (E) Thempr1-1 but not rpn11AXA mutation compromises assembly and peptidase activity of 26Sproteasome. Purified 26S proteasomes were resolved by electrophoresis on a 4% nondenaturing polyacrylamide gel and analyzed by Coomassie blue staining (top) or in-gel peptidase activity by incubating with the fluorescent peptidase substrate Suc-LLVY-AMC, as described in (6). (F) Point-mutant proteasomes with an altered JAMM motif are unable to deubiquitinate and degrade Ub-Sic1 in vitro. 26S proteasomes were prepared by anti-Flag affinity chromatography from RJD 1867 (mpr1-1 RPN11) and RJD 1868 (mpr1-1 rpn11AXA) cells expressing a chromosomally encoded FlagHis6-tagged Pre1. Purified proteasomes were incubated with 2.5 μM ubiquitin aldehyde at 30°C in the presence or absence of 100 μM epoxomicin. Ub-Sic1 and ATP-regenerating system were then added, and degradation was monitored as described in Fig. 1. Lanes 1 and 6 contain the 26S proteasome preparations from mpr1-1 RPN11 and mpr1-1 rpn11AXA, respectively, with no Ub-Sic1 added. The same samples were run on an 8% gel (top) as well as a 10% gel (bottom) to better visualize the Ub-Sic1 conjugates and unmodified Sic1.

Native gel electrophoresis followed by Coomassie blue staining and in-gel peptidase assay with a fluorogenic substrate (Fig. 4E) suggested that proteasomes from mpr1-1 cells were defective for assembly. Indeed, 26S proteasomes from thempr1-1 strain lacked subunits of the lid subcomplex of the 19S regulatory particle as judged by SDS–polyacrylamide gel electrophoresis (PAGE) (Fig. 4, B and C) and mass spectrometry (tables S1 and S2). Thus, the COOH terminus of Rpn11 was required either for stabilization of the lid or for association of the base and lid subcomplexes in vitro. By contrast, proteasomes recovered from both mpr1-1/RPN11 andmpr1-1/rpn11AXA cells were assembled into functional particles as judged by native gel electrophoresis (Fig. 4E), denaturing SDS-PAGE (Fig. 4B), and immunoblot analysis (Fig. 4D) and contained all 26S subunits as determined by mass spectrometry (table S1).

The “isogenic” Rpn11- and Rpn11AXA-containing 26S proteasomes were next tested for their ability to deubiquitinate and degrade Ub-Sic1. As expected, Rpn11-containing 26S proteasomes degraded Ub-Sic1, and preincubation with epoxomicin blocked degradation, leading to the accumulation of deubiquitinated Sic1 (Fig. 4F). In contrast, the Rpn11AXA26S proteasomes were profoundly defective for both activities. This result suggests a compelling biochemical rationale for the lethality of rpn11AXA.

We envision the following sequence of steps in the degradation cycle. After binding of a multiubiquitinated substrate to the 26S proteasome, the substrate is unfolded and threaded into the 20S core. Concomitantly, the substrate is deubiquitinated by the metalloisopeptidase activity of Rpn11. If Rpn11 activity is blocked, we envision that the tetraubiquitin chain targeting signal, which has a diameter of about 28 Å (as deduced from the crystal structure coordinates in the Protein Data Bank), would sterically block further substrate translocation upon collision with the entry portal of the 20S proteasome, which has a diameter comparable to that reported for Thermoplasma acidophilum (13 Å) (25). Substrate deubiquitination by Rpn11 thus defines a new, key step in protein degradation by 26S proteasome. Because deubiquitination of Ub-Sic1 requires ATP and is not sustained by a free lid or 19S regulatory particle, we propose that deubiquitination of a substrate is normally coupled tightly to its translocation into the 20S core. Although the mechanism underlying this coupling is unknown, we posit that it renders degradation vectorial by preventing deubiquitination until the substrate is irreversibly committed to proteolysis.

Eukaryotic proteasomes are distinguished from bacterial and archaeal ATP-dependent proteases primarily by their dependence on ubiquitin and the presence of the lid subcomplex (26). Highly specific targeting of substrates can be mediated by prokaryotic adenosine triphosphatases (ATPases) (27, 28), and Rpt5 ATPase appears to be the proteasomal receptor for ubiquitin chains (29). Taken together, these observations raise the question of why eukaryotic proteasomes have a lid. A unifying simplification emerges if one considers that a major—and perhaps only—function of the lid is to serve as a specialized isopeptidase that tightly couples the deubiquitination and degradation of substrates.

Supporting Online Material

Materials and Methods

Figs. S1 to S3

Tables S1 to S3

  • * To whom correspondence should be addressed. E-mail: deshaies{at}


View Abstract

Navigate This Article